Cerebrovascular Accident Risk Reduction in Hypertensive Patients with Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Cerebrovascular Accident Risk Reduction in Hypertensive Patients with Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-30FDA Approved: LOSARTAN POTASSIUM — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's Losartan Potassium as an original-application generic (ANDA 202230), granting marketing appr…